Posted by
First Generic Version of Epilepsy Drug Sabril Approved

First Generic Version of Epilepsy Drug Sabril Approved

THURSDAY, Jan. 17, 2019 (HealthDay News) — The first generic version of Sabril (vigabatrin) has been approved by the U.S. Food and Drug Administration to prevent complex partial seizures in adults and children 10 and older with epilepsy. Latest Neurology News “The availability of high-quality generic alternatives of critically important medicines, once the period of […]

Posted by
Stem Cell Transplant May Help Some With Aggressive MS

Stem Cell Transplant May Help Some With Aggressive MS

By Amy NortonHealthDay Reporter Latest Neurology News TUESDAY, Jan. 15, 2019 (HealthDay News) — A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds. The study focused on 110 patients with aggressive cases of MS: Their symptoms had flared up at least twice in […]

Posted by
FDA Clears Epilepsy Smartwatch for Use in Kids

FDA Clears Epilepsy Smartwatch for Use in Kids

By Megan BrooksWebMD Health News Jan. 15, 2019 — The FDA has cleared for marketing the Embrace smartwatch for seizure tracking in children as young as age 6. Latest Neurology News The Embrace, made by Empatica Inc., detects patterns in motion and signals from the body that may be associated with generalized tonic-clonic seizures and […]

Posted by
Drug May Delay MS Disability for Some

Drug May Delay MS Disability for Some

By Serena GordonHealthDay Reporter Latest Neurology News WEDNESDAY, Jan. 9, 2019 (HealthDay News) — An immune system drug may help prevent or slow complications in a type of multiple sclerosis known as secondary progressive MS, a new study finds. The medication is called rituximab (Rituxan). It’s used to treat a number of conditions, including certain […]

Posted by
Be Alert for Concussions in Young Athletes

Be Alert for Concussions in Young Athletes

Latest Neurology News TUESDAY, Jan. 1, 2019 (HealthDay News) — With youth winter sports in full swing, it’s important for coaches and parents to know the signs of a concussion, a sports medicine doctor says. “Because concussion can affect thinking, the person who suffered the injury might not realize there is a problem,” said Dr. […]

Posted by
People With Movement Disorders May Become Immune to Botox Therapy

People With Movement Disorders May Become Immune to Botox Therapy

Latest Neurology News FRIDAY, Dec. 28, 2018 (HealthDay News) — Some people who receive botulinum toxin injections for disorders that cause muscle tightness and contractions develop resistance to the treatment, researchers say. The new study included nearly 600 patients with dystonia or spasticity who had been receiving botulinum toxin type A (commonly known as “Botox“) […]

Posted by
Myasthenia Gravis

Myasthenia Gravis

What should I know about myasthenia gravis?* *This myasthenia gravis section written by Charles Patrick Davis, MD, PhD What is the medical definition of myasthenia gravis? Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by varying degrees of weakness of the skeletal (voluntary) muscles of the body. The thymus may give incorrect instructions to […]

Posted by
levodopa-carbidopa, Sinemet, Sinemet CR, Parcopa

levodopa-carbidopa, Sinemet, Sinemet CR, Parcopa

What is levodopa-carbidopa, and how does it work (mechanism of action)? Carbidopa-levodopa is a combination of two drugs, levodopa and carbidopa. Carbidopa-levodopa is used in the treatment of Parkinson’s disease. Parkinson’s disease is believed to be caused by low levels of dopamine in certain parts of the brain. When levodopa is taken orally, it crosses […]

Posted by
valproic acid, divalproex, Depakote, Depakote Sprinkle, Depakote ER, Depakene, Depacon, Stavzor

valproic acid, divalproex, Depakote, Depakote Sprinkle, Depakote ER, Depakene, Depacon, Stavzor

Which drugs or supplements interact with valproic acid? Valproic acid has numerous suspected or proven drug interactions. Valproic acid can reduce the number of platelets or inhibit the ability of platelets to stick together and form a blood clot. Therefore, it may exaggerate the effects of other medications which inhibit the stickiness of platelets or […]

Posted by
FDA Warns of Rare Stroke Risk With MS Drug

FDA Warns of Rare Stroke Risk With MS Drug

Latest Neurology News WEDNESDAY, Dec. 5, 2018 (HealthDay News) — A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug Administration said. Most patients with these problems […]